Seven Eight Capital’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,500	Closed	-$394K	–	621
2020 Q2	$394K	Buy	+7,500	New	+$313K	0.29%	123
2020 Q1	–	Sell	-15,886	Closed	-$720K	–	633
2019 Q4	$720K	Sell	15,886 -16,589	-51%	-$705K	0.04%	488
2019 Q3	$1.24M	Buy	32,475 +2,200	+7%	+$87.8K	0.07%	393
2019 Q2	$1.32M	Buy	+30,275	New	+$1.29M	0.07%	352
2018 Q4	–	Sell	-6,275	Closed	-$308K	–	670
2018 Q3	$308K	Buy	+6,275	New	+$271K	0.02%	511
2017 Q3	–	Sell	-957	Closed	-$46K	–	566
2017 Q2	$46K	Buy	+957	New	+$44.4K	0.01%	486
2017 Q1	–	Sell	-2,401	Closed	-$78K	–	640
2016 Q4	$78K	Sell	2,401 -5,500	-70%	-$184K	0.02%	476
2016 Q3	$270K	Buy	7,901 +6,000	+316%	+$235K	0.08%	286
2016 Q2	$64K	Buy	+1,901	New	+$93.4K	0.02%	435
2016 Q1	–	Sell	-801	Closed	-$62K	–	650
2015 Q4	$62K	Buy	801 +800	+80,000%	+$45.3K	0.04%	415
2015 Q3	$0	Buy	+1	New	+$61	﹤0.01%	646
2015 Q2	–	Sell	-601	Closed	-$53K	–	634
2015 Q1	$53K	Buy	+601	New	+$61K	0.09%	280
2014 Q4	–	Sell	-3,501	Closed	-$339K	–	609
2014 Q3	$339K	Buy	+3,501	New	+$341K	0.26%	136
2014 Q2	–	Sell	-10,100	Closed	-$707K	–	579
2014 Q1	$707K	Buy	+10,100	New	+$687K	0.61%	40